Sanofi India MD Rajaram Narayanan (Photo| Special Arrangement) 
Business

Sanofi India MD Rajaram Narayanan resigns, to 'pursue an opportunity outside' company

Chairman Aditya Narayan noted that under Rajaram's leadership Sanofi India has implemented a variety of transformational initiatives to deliver market-beating growth in key therapies.

PTI

NEW DELHI: Drug firm Sanofi India on Thursday said its Managing Director Rajaram Narayanan has put in his papers. Sanofi India said in a statement that the company's board has accepted the resignation of Narayanan, effective from the close of business hours on April 10, 2022.

Narayanan has decided to pursue an opportunity outside of Sanofi, it added. His successor will be appointed in due course, the drug firm stated.

"Under Rajaram's leadership Sanofi India has successfully implemented a variety of transformational initiatives to deliver market-beating growth in key therapies and significantly improve its overall financials," Sanofi India Chairman Aditya Narayan noted.

Congress slams Modi over Lok Sabha seats expansion plan, calls it 'Weapon of Mass Distraction'

'WE GOT HIM!': Trump says missing US airman rescued as Iran claims it downed search aircraft

No CM face in Bengal polls, BJP to seek votes in Modi’s name: State chief Samik Bhattacharya

Amid AAP row over claims he failed to raise Punjab issues in Parliament, Chadha hits back, defends record

BJP redraws Assam campaign plank from infiltration to youth welfare as April 9 polls near

SCROLL FOR NEXT